Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in YARW — Yarrow Bioscience, Inc.

CIK 1595888 NEW YORK, NY
Back to YARW Full portfolio

Position in YARW

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$26,673
-$30,522 QoQ
Shares Held
819
-57.2% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 44 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in YARW Over Time

Shares Held

Position Value (USD)

Derivatives in YARW

reported options exposure · as of Mar 31, 2020
CallValue
$0
CallShares
0
PutValue
$0
PutShares
29,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names. YARW ranks #265 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in YARW

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $26,673 40,974
2026-03-31 $57,195 95,645
2025-12-31 $41,965 72,356
2025-09-30 $49,284 147,120
2025-06-30 $205,955 124,822
2024-12-31 $67,957 20,286